loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (DMF) of Oxtriphylline Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Oxtriphylline

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    26/09/2024 Abbott Laboratories
    U.S.A
    		 KNOLL AG LUDWIGSHAFEN 4013 CHOLINE THEOPHYLLINATE (OXTRIPHYLLINE) 1980-12-15 Inactive II N/A
    26/09/2024 ORGAMOL PHARMA SOLUTIONS SA
    Switzerland
    		 ORGAMOL SA 3475 CHOLINE THEOPHYLLINATE 1978-12-22 Inactive II N/A